We found that rHuEPO treatment did not change VEGF expression (versus PBS control), although Batra et al.28 previously reported that exogenous erythropoietin increased the production and secretion of angiogenic growth factors, vascular endothelial growth factor, and placenta growth factor from tumor cell lines. Here, EPO is linked to neoplasm.